Impact of tumor grade on pancreatic cancer prognosis: Validation of a novel TNMG staging system

Annals of Surgical Oncology

Volumn 20, Issue 13, 2013, Pages 4322-4329

  Rochefort, Matthew M ^a,b   Ankeny, Jacob S ^a,b   Kadera, Brian E ^b   Donald, Graham W ^b   Isacoff, William ^b   Wainberg, Zev A ^b   Joe Hines, O ^b   Donahue, Timothy R ^b   Reber, Howard A ^b   Tomlinson, James S ^a,b  

^a VA GREATER LOS ANGELES HEALTHCARE SYSTEM   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGE DISTRIBUTION; AGED; ARTICLE; CANCER GRADING; CANCER PROGNOSIS; CANCER REGISTRY; CANCER SIZE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; DISEASE CLASSIFICATION; FEMALE; HUMAN; LYMPH NODE; MAJOR CLINICAL STUDY; MALE; PANCREAS ADENOCARCINOMA; PANCREAS RESECTION; PANCREATICODUODENECTOMY; SEX DIFFERENCE; TUMOR.NODE,METASTASIS,GRADE CLASSIFICATION SYSTEM; VALIDATION PROCESS;

ADENOCARCINOMA; AGED; CARCINOMA, PANCREATIC DUCTAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; LYMPHATIC METASTASIS; MALE; NEOPLASM GRADING; NEOPLASM STAGING; PANCREATIC NEOPLASMS; PROGNOSIS; PROSPECTIVE STUDIES; SURVIVAL RATE; VALIDATION STUDIES AS TOPIC;

EID: 84892373053     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-013-3159-3     Document Type: Article

References (16)

1. National Institutes of Health. National Cancer Institute. Tumor grade fact sheet. Available at: http://www.cancer.gov/cancer topics/factsheet/ detection/tumor-grade.
2. Edge SBB, Compton DR, Fritz CC, Greene AG, Trotti FL, editors. AJCC cancer staging manual. 7th ed. New York: Springer; 2010.
3. Wasif N, Ko CY, Farrell J, et al. Impact of tumor grade on prognosis in pancreatic cancer: should we include grade in AJCC staging? Ann Surg Oncol. 2010;17:2312-20.
4. Brennan MF, Kattan MW, Klimstra D, Conlon K. Prognostic nomogram for patients undergoing resection for adenocarcinoma of the pancreas. Ann Surg. 2004;240:293-8.
5. Ferrone CR, Kattan MW, Tomlinson JS, Thayer SP, Brennan MF, Warshaw AL. Validation of a postresection pancreatic adenocarcinoma nomogram for disease-specific survival. J Clin Oncol. 2005;23:7529-35.
6. Geer RJ, Brennan MF. Prognostic indicators for survival after resection of pancreatic adenocarcinoma. Am J Surg. 1993;165:68-72.
7. Lim JE, Chien MW, Earle CC. Prognostic factors following curative resection for pancreatic adenocarcinoma: a populationbased, linked database analysis of 396 patients. Ann Surg. 2003;237:74-85.
8. Winter JM, Cameron JL, Campbell KA, et al. 1423 pancreaticoduodenectomies for pancreatic cancer: a single-institution experience. J Gastrointest Surg. 2006;10:1199-210.
9. Benassai G, Mastrorilli M, Quarto G, et al. Factors influencing survival after resection for ductal adenocarcinoma of the head of the pancreas. J Surg Oncol. 2000;73:212-8.
10. Hartwig W, Hackert T, Hinz U, et al. Pancreatic cancer surgery in the new millennium: better prediction of outcome. Ann Surg. 2011;254:311-9.
11. Vinay Kumar AKA, Fausto N, Aster J, editors. Robbins and Cotran pathologic basis of disease. 8th ed. New York: Elsevier; 2010.
12. Nathan H, Pawlik TM. Limitations of claims and registry data in surgical oncology research. Ann Surg Oncol. 2008;15:415-23.
13. Gebhardt C, Meyer W, Reichel M, Wunsch PH. Prognostic factors in the operative treatment of ductal pancreatic carcinoma. Langenbecks Arch Surg. 2000;385:14-20.
14. Oettle H, Post S, Neuhaus P, et al. Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer: a randomized controlled trial. JAMA. 2007;297:267-77.
15. Neoptolemos JP, Stocken DD, Friess H, et al. A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer. N Engl J Med. 2004;350:1200-10.
16. Vanderveen KA, Chen SL, Yin D, Cress RD, Bold RJ. Benefit of postoperative adjuvant therapy for pancreatic cancer: a population- based analysis. Cancer. 2009;115:2420-9.